Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
- Author
- PAPP, K. A1 ; GRIFFITHS, C. E. M2 ; STROBER, B1 8 ; REICH, K9 ; GORDON, K3 ; LEBWOHL, M4 ; SZAPARY, P. O5 ; WASFI, Y5 ; CHAN, D5 ; HSU, M.-C5 ; HO, V6 ; GHISLAIN, P. D7
[1] Probity Medical Research, 135 Union Street East, Waterloo, ON N2J1C4, Canada
[2] Dermatology Centre, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom
[3] Feinberg School of Medicine, Northwestern University, Chicago, IL, United States
[4] Mount Sinai School of Medicine, New York, NY, United States
[5] Janssen Research & Development, LLC, Spring House, PA, United States
[6] University of British Columbia, Vancouver, BC, Canada
[7] Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
[8] Department of Dermatology, University of Connecticut School of Medicine, Farmington, CT, United States
[9] Dermatologikum Hamburg, Hamburg, Germany
ACCEPT Investigators - Source
British journal of dermatology (1951). 2013, Vol 168, Num 4, pp 844-854, 11 p ; ref : 58 ref
- CODEN
- BJDEAZ
- ISSN
- 0007-0963
- Scientific domain
- Dermatology
- Publisher
- Wiley-Blackwell, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Dermatologie Grave Homme Long terme Malade Psoriasis Résultat Surveillance Sécurité Forme grave Pathologie de la peau
- Keyword (en)
- Dermatology Severe Human Long term Patient Psoriasis Result Surveillance Safety Skin disease
- Keyword (es)
- Dermatología Grave Hombre Largo plazo Enfermo Psoriasis Resultado Vigilancia Seguridad Piel patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B08 Dermatology / 002B08D Psoriasis. Parapsoriasis. Lichen
- Discipline
- Dermatology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27242786
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/bjd.12214 
https://dx.doi.org/10.1111/bjd.12214
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1111\/bjd.12214\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up\";s:9:\"\u0000*\u0000jtitle\";s:37:\"British journal of dermatology (1951)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Br. j. dermatol. (1951)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"168\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"844\";s:8:\"\u0000*\u0000epage\";s:3:\"854\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"PAPP\";s:10:\"\u0000*\u0000aufirst\";s:4:\"K. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:18:\"GRIFFITHS, C. E. M\";i:1;s:10:\"STROBER, B\";i:2;s:8:\"REICH, K\";i:3;s:9:\"GORDON, K\";i:4;s:10:\"LEBWOHL, M\";i:5;s:13:\"SZAPARY, P. O\";i:6;s:8:\"WASFI, Y\";i:7;s:7:\"CHAN, D\";i:8;s:9:\"HSU, M.-C\";i:9;s:5:\"HO, V\";i:10;s:14:\"GHISLAIN, P. D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJDEAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1111\/bjd.12214\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up\";s:9:\"\u0000*\u0000jtitle\";s:37:\"British journal of dermatology (1951)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Br. j. dermatol. (1951)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"168\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"844\";s:8:\"\u0000*\u0000epage\";s:3:\"854\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"PAPP\";s:10:\"\u0000*\u0000aufirst\";s:4:\"K. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:18:\"GRIFFITHS, C. E. M\";i:1;s:10:\"STROBER, B\";i:2;s:8:\"REICH, K\";i:3;s:9:\"GORDON, K\";i:4;s:10:\"LEBWOHL, M\";i:5;s:13:\"SZAPARY, P. O\";i:6;s:8:\"WASFI, Y\";i:7;s:7:\"CHAN, D\";i:8;s:9:\"HSU, M.-C\";i:9;s:5:\"HO, V\";i:10;s:14:\"GHISLAIN, P. D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJDEAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:17:\"10.1111\/bjd.12214\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1111\/bjd.12214\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up\";s:9:\"\u0000*\u0000jtitle\";s:37:\"British journal of dermatology (1951)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Br. j. dermatol. (1951)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"168\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"844\";s:8:\"\u0000*\u0000epage\";s:3:\"854\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"PAPP\";s:10:\"\u0000*\u0000aufirst\";s:4:\"K. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:18:\"GRIFFITHS, C. E. M\";i:1;s:10:\"STROBER, B\";i:2;s:8:\"REICH, K\";i:3;s:9:\"GORDON, K\";i:4;s:10:\"LEBWOHL, M\";i:5;s:13:\"SZAPARY, P. O\";i:6;s:8:\"WASFI, Y\";i:7;s:7:\"CHAN, D\";i:8;s:9:\"HSU, M.-C\";i:9;s:5:\"HO, V\";i:10;s:14:\"GHISLAIN, P. D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJDEAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1111\/bjd.12214\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up\";s:9:\"\u0000*\u0000jtitle\";s:37:\"British journal of dermatology (1951)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Br. j. dermatol. (1951)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"168\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"844\";s:8:\"\u0000*\u0000epage\";s:3:\"854\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"PAPP\";s:10:\"\u0000*\u0000aufirst\";s:4:\"K. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:18:\"GRIFFITHS, C. E. M\";i:1;s:10:\"STROBER, B\";i:2;s:8:\"REICH, K\";i:3;s:9:\"GORDON, K\";i:4;s:10:\"LEBWOHL, M\";i:5;s:13:\"SZAPARY, P. O\";i:6;s:8:\"WASFI, Y\";i:7;s:7:\"CHAN, D\";i:8;s:9:\"HSU, M.-C\";i:9;s:5:\"HO, V\";i:10;s:14:\"GHISLAIN, P. D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJDEAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1111\/bjd.12214\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up\";s:9:\"\u0000*\u0000jtitle\";s:37:\"British journal of dermatology (1951)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Br. j. dermatol. (1951)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"168\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"844\";s:8:\"\u0000*\u0000epage\";s:3:\"854\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-0963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"PAPP\";s:10:\"\u0000*\u0000aufirst\";s:4:\"K. A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:18:\"GRIFFITHS, C. E. M\";i:1;s:10:\"STROBER, B\";i:2;s:8:\"REICH, K\";i:3;s:9:\"GORDON, K\";i:4;s:10:\"LEBWOHL, M\";i:5;s:13:\"SZAPARY, P. O\";i:6;s:8:\"WASFI, Y\";i:7;s:7:\"CHAN, D\";i:8;s:9:\"HSU, M.-C\";i:9;s:5:\"HO, V\";i:10;s:14:\"GHISLAIN, P. D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJDEAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
